Companies / Sana Biotechnology, Inc.

Sana Biotechnology, Inc.

Nasdaq: SANACIK 1770121SEATTLE, WAsana.com

Financials

Revenue
Net income$-244.17M
Total debt
Cash$57.07M
Diluted EPS$-0.96
Shares outstanding299.4M

Ownership

299.4M shares outstanding · as of Aug 3, 2026
4.6%Insiders
Ownership
Insiders4.60%13,784,991
10%+ / strategic4.56%13,643,304
Institutions49.83%149,168,818
Public float41.01%122,763,524

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Harr SteveCEOPresident & CEO · Director
2.65%7,944,251
1.95%5,840,740
Wyrick Susan D.FormerSee Remarks
0.07%196,196
Nelsen RobertDirector · 10% owner
Patel Dhavalkumar DhirajlalFormerEVP, Chief Scientific Officer
Piper BrianFormerEVP, Chief Financial Officer

Institutional holders 208

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 9, 2026Harr Steve
CEO
OtherCommon Stock$39.7K-13K
-0.16%
7,944,251
2.65% of shares
low
Mar 9, 2026Harr Steve
CEO
OtherCommon Stock$36.1K-12K
-0.14%
7,957,070
2.66% of shares
low
Mar 9, 2026Wyrick Susan D.
Executive
OtherCommon Stock$10.5K-3K
-1.67%
197,241
0.07% of shares
low
Jan 5, 2026Wyrick Susan D.
Executive
OtherCommon Stock$10.3K-2K
-1.28%
185,883
0.06% of shares
low
Mar 9, 2026Wyrick Susan D.
Executive
OtherCommon Stock$3.2K-1K
-0.53%
196,196
0.07% of shares
low
Mar 3, 2026Wyrick Susan D.
Executive
OtherCommon Stock$1.9K-491
-0.26%
186,917
0.06% of shares
low
Mar 7, 2026Harr Steve
CEO
ExerciseCommon Stock$0+50K
+0.63%
7,968,596
2.66% of shares
low
Mar 6, 2026Harr Steve
CEO
ExerciseCommon Stock$0+42K
+0.53%
7,918,596
2.65% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
BlackRock, Inc.Passive13G13,643,304
RA Capital Management, L.P.Passive13G

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SANA799566104